Spanish colorectal cancer group reports progress of screening-awareness drive
This article was originally published in Clinica
Spanish colorectal cancer charity and pressure group Europacolon España is claiming significant progress in raising public awareness of the risk factors associated with the condition and of the importance of screening.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.